Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study.

Cardiovasc Diabetol · 2023 · PMC10552437 · PMID 37794465

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Except for renal death, marginally significant effects of the interactions between CVD history (i.e., with versus without established CVDs) and treatment status (i.e., GLP-1RAs versus LAIs) on the risk of the composite chronic renal outcome ( p = 0.093), renal insufficiency (i.e., eGFR < 15 mL/min/1.73 m 2 ) ( p = 0.064), and dialysis-dependent ESRD ( p = 0.054) were found.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.